Ascentage Pharma Group International (NASDAQ:AAPG - Get Free Report)'s share price was down 4% during mid-day trading on Tuesday . The company traded as low as $19.58 and last traded at $19.58. Approximately 708 shares were traded during trading, a decline of 99% from the average daily volume of 81,598 shares. The stock had previously closed at $20.40.
Analyst Upgrades and Downgrades
Separately, JPMorgan Chase & Co. initiated coverage on Ascentage Pharma Group International in a report on Thursday, March 27th. They set an "overweight" rating on the stock.
Get Our Latest Report on Ascentage Pharma Group International
Ascentage Pharma Group International Stock Performance
The stock has a 50-day simple moving average of $19.53.
About Ascentage Pharma Group International
(
Get Free Report)
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Further Reading
Before you consider Ascentage Pharma Group International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ascentage Pharma Group International wasn't on the list.
While Ascentage Pharma Group International currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
